__MAIN_TEXT__
feature-image

Page 1

2020 A N N UA L REPORT

A Look Back / A Look Ahead


D E A R C O L L E AG U E S : Before we can look to where we’re going, we need to look to where we’ve been. This has been a challenging year for the SVS Foundation, the SVS and all its members. A year that began with promise and excitement over the second annual ‘Vascular Spectacular’ gala became the Year of the Pandemic instead. COVID19 halted elective—but medically necessary—surgeries, upended our members’ practices and created economic uncertainty. It also canceled our Vascular Annual Meeting and our Foundation Gala.

A LOOK BACK, A LOOK AHEAD

The pandemic is not yet tamed, though some equilibrium has returned with the resumption of elective surgeries and the training of our future colleagues in surgery. We remain not only hopeful, but excited, in looking ahead to the future of the SVS Foundation. We have done some major restructuring (see the next page): we’ve changed terms of the chair to provide continuity, altered the chair selection process and added board members who are friends of vascular surgery from outside the SVS itself. All of these changes make us stronger. New voices offer alternatives and put us in touch with a greater number of people and initiatives. We have additional stability.

CORE MISSION OF THE SVS F O U N D AT I O N To optimize the vascular health and well-being of patients and the public through support of research that leads to discovery of knowledge and innovative strategies, as well as education and programs, to prevent and treat circulatory disease.

Yet we have the same ultimate goal: to improve patient care: through public education and awareness, through research with the support of Foundation grants and scholarships. As chair, I hope to promote prospective research, particular device research—not readily available in managing venous and arterial disease but of critical importance— that could lead to better treatment options for our patients. Such research is difficult to conduct, but necessary to be able to make the best decisions on treatment. We will also review all current and existing programs and consider new programs in both education and research. And as we have done in the past, we will continue to partner with other foundations. I congratulate and thank all who have donated to the SVS Foundation in the past, particularly this past year. And I want to encourage anyone who has never donated to make 2020 the year that changes. Become a first-time donor! After all, the need is as great as ever. Foundations are mission-driven and thrive with the support of donations. Simply put, the more money, the greater the mission. We can change and enhance vascular health and knowledge and ultimately, as always is our goal, improve patient care. I ask all of you to be generous in supporting your Foundation and allowing it to continue to find better solutions in treating vascular disease. Yours truly,

Peter F. Lawrence, MD Chair, SVS Foundation


SVS FOUNDATION MAKES STRUCTURAL CHANGES TO FOUNDATION BOARD the Foundation in 2015-16, as the new chair. New public members are “friends of the SVS” Marty Sylvain and James Neupert.

The SVS Foundation Board of Directors has altered its infrastructure, including expanding the board and adding seats specifically for public members and changing the term of the Foundation chair to a three-year instead of a oneyear term.

Lisa K. Bennett, Peter Brant-Zawadzki,

• Developing criteria for evaluation of current and future programs

Besides Dr. Lawrence, other members

65 9%

corporate support

Gala sales

percent of donations go directly to support awards

fundraising

20%

external to the Society and Foundation

16%

Dr. Lawrence and Drs. Nilesh Balar, Rocco Ciocca, Sarasi K. Desikan, Chandu Vemuri and Mohamed Zayed.

of the FOUNDATION BOARD OF DIRECTORS are Treasurer Keith Calligaro; Edith Tzeng, chair of the Research Council; SVS President Ron Dalman; President-Elect Ali

Outgoing President Dr. Kim Hodgson thanked Dr. Makaroun for his work, particularly with adding the SVS Foundation “Vascular Spectacular” Gala to the Vascular Annual Meeting (canceled this year along with the in-person meeting.) Dr. Hodgson called the restructuring “an outstanding idea and an outstanding accomplishment.”

33% 19%

Thomas Forbes (vice chair),

• Creating three-year terms for board members, with the exception of staggered terms for the first cycle to provide continuity

9%

percent of Foundation income contributed by individuals & departments

are Drs. Peter Nelson (chair),

• Amending of bylaws to enact the changes

In addition, the immediate past president of the SVS will no longer succeed to the chair position but will serve on the Foundation board. In announcing these changes at the first SVS Annual Business Meeting on June 15, Dr. Makaroun named Peter Lawrence, MD., who chaired

30

DEVELOPMENT COMMITTEE

Other infrastructure changes include:

Expanding the board provides for broader representation while the three-year term for the chair provides continuity, said Michel S. Makaroun, MD, whose term as chair ended in June. The changes as a whole “position the SVS Foundation Board for further growth,” he said.

2020 SVS FOUNDATION FISCAL YEAR HIGHLIGHTS

Members of the SVS FOUNDATION

gala fundraising

AbuRahma; Immediate Past President Kim Hodgson; and surgeons William Shutze, Richard Lynn, Matt Eagleton, Joseph Hart and Nasim Hedayati; Executive Director Patricia Burton, ex officio. Marty Sylvain and James Neupert are non-surgeon members.

17.47

percent of Active members in North America who are contributors

administration

$6,257,035* Total liabilities and equity

*Unaudited financial statements; includes cash, investments and value of pledges for future support

100

percent of SVS Foundation Board members who are contributors


MAKING HIS FIRST DONATION, BUT NOT HIS L AST SVS member Dr. Daniel Alterman last year made his first contribution to the SVS Foundation. It will not be his last. In fact, he plans on annual contributions becoming “a recurring habit.” “The need is there,” said Dr. Alterman, who practices in Muskegon, Mich. “And it’s my professional responsibility.” Dr. Daniel Alterman, MD

“The need is there. And it’s my professional responsibility.”

COMMUNIT Y GRANTS

As a member in private practice, he is not involved in academics or basic or clinical research, mainstays of SVS Foundation grants. “But I feel passionate about helping support researchers,” he said, noting he has participated in research in the past and had articles published in the Journal of Vascular Surgery. He also has participated in quality initiatives at the regional and state level.

Beyond research grants, Dr. Alterman noted, the Foundation funds community project initiatives, screenings and public awareness, including the patient education fliers he features in his own office. “Community involvement and public awareness are important initiatives,” he said. “They help educate and let the community know what we do. Most patients don’t know what a vascular surgeon is, and some hospital administrators aren’t sure, either, so letting people know we’re here and what we do is important.” He finds contributing to the SVS Foundation important for community practitioners. “In community practice, you can get siloed. You tend to lose contact with the pulse of academics. So it’s important to me to get involved to the extent that I can to support these kind of programs.” ■

Grant Helps Amputees Get Up and Walk More Quickly A G R A N T F R O M T H E S V S F O U N DAT I O N H A S H E L P E D A M P U T E E S I N T H E F R E S N O, C A L I F O R N I A A R E A G E T U P A N D WA L K I N G M O R E Q U I C K LY T H A N I S T Y P I C A L .

SVS member and researcher Leigh Ann O’Banion now hopes this success can be duplicated across the country. All patients were treated following the LEAP—Lower Extremity Amputation Pathway—protocol. LEAP mandates not only a multidisciplinary approach with consultations involving a raft of providers, but also post-operative discharge into an acute rehabilitation facility.

Dr. Leigh Ann O’Banion, MD

2

SVS F OU N DATI O N

Dr. O’Banion created the LEAP protocol and is overseeing the study, with assistance from a 2019 SVS Foundation Community Awareness and Prevention Project Grant. The project involves a

| 2020 A N N UA L R E P O RT

prospective study of all dysvascular patients who have undergone major lower-extremity amputations at University of California Fresno from January 2018 onward. To date, 11 patients have been enrolled; however, enrollment was abruptly halted by the COVID-19 pandemic. UCSF-Fresno is anticipating completion of enrollment of the project once clinical research can safely resume. Under LEAP, vascular patients at risk for major lower extremity amputations consult with anesthesiologists, surgeons, social workers, physical therapists, rehab personnel and prosthetists. Patients are discharged into an acute


rehabilitation facility as opposed to a nursing home or home, a key component, said Dr. O’Banion. Additionally, all patients received physical therapy “on or before the day of their amputation,” she said. The results thus far, she said, “are extremely promising.”

in post-operative hospital length of stay (three vs six days) and had a significantly higher rate of receiving a prosthetic (100 percent vs. 54 percent). In addition, the LEAP patients received their prosthetics and ambulated on average a month sooner than their historical controls.

LEAP patients all received physical therapy two days sooner than a retrospective cohort of 130 amputees and hospital length of stay was decreased, on average, three days. LEAP patients received their prosthetics and ambulated, on average 56 days sooner than the retrospective cohort (p=0.002).

Fresno and the Central Valley is an area underserved in vascular care and previously was at the top of California’s amputation rankings, Dr. O’Banion said. “There is a true need for the LEAP protocol and improved outcomes in vascular patients requiring amputation,” she said.

LEAP patients also were matched to a subset of patients in the retrospective cohort who were discharged to an acute rehab facility. LEAP patients had a 50 percent reduction

Such a standardized peri-operative protocol does not currently exist for dysvascular patients, who account for more than 80 percent of all major lower extremity amputations in the

United States. This specific patient population is older, with increased medical co-morbidities and therefore predisposed to deconditioning faster than the younger traumatic and oncologic amputee population, said Dr. O’Banion. She will continue enrollment to the planned-for 20+ patients, when research restrictions ease, anticipating continued success. She feels the project has momentum now that early results are in, and that the elements for success are already in place. “This is a protocol that utilizes resources available to most hospital systems nationwide,” she said. “It is our goal that the protocol can be duplicated and adopted across the country. There’s a real potential to impact our vascular patients’ lives all over the country.” ■

3


CO M M U N IT Y G R A NTS

Photos provided by the University of Oklahoma

Dr. Kelly Kempe, MD

Foundation Community Grant Assists in Efforts to Reduce Amputation Rate M A N Y S V S M E M B E R S A R E H A R D AT W O R K I M P R OV I N G T H E H E A LT H O F M E M B E R S O F T H E I R C O M M U N I T I E S . I N 2 0 1 8 , T H E S V S F O U N DAT I O N E X PA N D E D I T S M I S S I O N TO I N C LU D E P R OJ E C T S T H AT I M PAC T VA S C U L A R H E A LT H , AWA R E N E S S A N D P R E V E N T I O N , A N D W I T H T H AT C A M E T H E S V S F O U N DAT I O N C O M M U N I T Y AWA R E N E S S A N D P R E V E N T I O N P R OJ E C T ( C A P P ) G R A N T. R E C I P I E N T S O F T H E AWA R D, W H O M U S T B E C O M M U N I T Y- B A S E D VA S C U L A R S U R G E O N S , R E C E I V E U P TO $1 0 , 0 0 0 F O R T H E I R C O M M U N I T Y- B A S E D I N I T I AT I V E S . T H E 2 02 0 G R A N T WA S AWA R D E D TO K E L LY K E M P E , M D, W H O S E P R OJ E C T C E N T E R S O N H E L P I N G T H O S E I N H E R A R E A O F O K L A H O M A AT R I S K F O R VA S C U L A R D I S E A S E .

Dr. Kelly Kempe, who practices vascular surgery at the University of Oklahoma, School of Community Medicine, has a personal mission: “To reduce the amputation rate in Oklahoma.” With her grant, she is able to pair up with the Oklahoma Primary Healthcare Improvement Cooperative (OPHIC) to partner with primary care providers and decipher how amputation rates can be reduced to reach her goal. Dr. Kempe began collaborating with OPHIC during her research. The cooperative focuses on the dissemination and implementation of evidence-based practices in primary care and has extensive experience aiding primary care practices to improve their patients’ cardiovascular risk. Not only do OPHIC’s goals align perfectly with vascular surgery, but the cooperative also has received funding to improve cardiovascular care and diabetes prevention from the Centers for Disease Control through the Oklahoma State Department of Health, said Dr. Kempe. “We would like to understand what primary care practices view as a top priority in their practice to reduce the amputation rate in Oklahoma,” she said.

“Oklahomans face major challenges as evidenced by some of the highest rates of diabetes, obesity, hypertension and cardiac deaths in the United States,” she said. The state ranks 50th in overall health system performance with particularly low marks in access to care, plus approximately one-third of the population is rural. This adds “an additional barrier to optimal health care,” she said. In addition, there are only 12 board-certified vascular surgeons working in the state. Primary care providers are the main source of health care in the state. Dr. Kempe is working to find a way to understand the barriers they face, inquire about their practice and recognition of at-risk limbs, and describe the process required to refer these patients to a vascular specialist. This first step is crucial to achieve her goal. “With a large burden of disease, few vascular providers, poor access to care and an overall weak infrastructure, Oklahoma is in a difficult position to try and prevent and reduce amputations,” she said. ■

Learn more about the grants at vsweb.org/CommunityGrants. The 2021 deadline is March 1.

4

SVS F OU N DATI O N

| 2020 A N N UA L R E P O RT


CO M M U N IT Y G R A NTS

Foundation Grants and Mentors Touch the Future

THIS YEAR, 11 MEDICAL STUDENTS RECEIVED RESEARCH G R A N T S F R O M T H E S V S F O U N DAT I O N .

Will the research project on Wi-Fi scores, limb salvage outcomes and racial groups show results in terms of a patient therapy? How about a study on assessing t he causes for lower intervention rates among women with thoracoabdominal aortic aneurysms? When? The answers are “unknown” and “perhaps never.” But the value of those research grants—and other grants to younger researchers—are incalculable. “The results are not necessarily immediate,” explained Katherine Gallagher, MD, of the University of Michigan, mentor to several young surgeon-scientists. But the grants importantly spur students’ “interest and desire and give them an opportunity and a forum to get involved in research.” And that research, she said, can advance treatments for vascular disease and impact patient care. A shortage currently exists national of surgeons involved in research, which means a shortage of research in vascular disease, said Dr. Gallagher. Thus, the Society for Vascular Surgery and the National Institutes of Health are working

SVS FOUNDATION ANNOUNCES AWARDS, GRANTS

to increase the number of surgeon-researchers through attracting younger people. “Our opportunities, with a project and a mentor, provide a segue to for them to get involved in research, with the hope that a certain percentage will pursue a career in that arena.” Some of her past mentees are now independent surgeonscientists working in translational research; other mentees are headed that way. Each has contributed to a pipeline to the future, of sorts. “They inspire the next generation of residents behind them,” she said. “They’ve gotten their younger peers excited about research and brought more young people into the pipeline, who are more interested in vascular research AND in vascular surgery as a career.” All have been very, very successful in their own way, she said. “They’ve touched vascular surgery, certainly, in different ways. I think all of them will have an impact on our specialty, on our patients, our research and in different arenas.” Dr. Gallagher is proud of each and every one of them. “I love inspiring the next generation,” she said. “I like the excitement when they start designing projects and running their first experiment, when they stay with it and troubleshot for themselves and work through parts that don’t work at first. Those are important life lessons, as well as research lessons,” she said. As is the case with her own children, she said, “I’m happier by their successes than by my own. I want to see them succeed, and I try to help them in any way that I can.” “They’re going to change the world.” ■

Bridge Grant

Resident Research Award

BEST-CLI Investigators

Mitri K. Khoury, MD General Surgery Resident, University of Texas, Southwestern (Graduate 2022) T32 Vascular Research Fellow, University of Wisconsin, Madison

Dr. Matthew Menard Brigham and Women's Hospital Dr. Alik Farber Boston University Medical Center

E.J. Wylie Traveling Fellowship Cassius Iyad Ochoa Chaar, MD, MS Yale University School of Medicine

SVS Foundation and American College of Surgeons Mentored Clinical Scientist Research Career Development Award (K08) Areck A. Ucuzian, MD, PhD University of Maryland School of Medicine

Clinical Research Seed Grant Mohammad Qadura MD, PhD University of Toronto

MENTOR: Bo Liu, PhD

Research Career Development Travel Award John Byrne, MD University of Toronto Nathan Liang, MD University of Pittsburgh Mohammad Qadura MD, PhD University of Toronto

5


Community Awareness and Prevention Project Grant

Student Research Fellowship Awards

Kelly Kempe, MD University of Oklahoma School of SVS Medicine FOUNDATION Community

Kamran Ali University of Chicago SPONSOR: Ross Milner, MD

VRIC Trainee TravelGRANTS Awards AWARDS,

Thomas Wen-Tao Cheng Boston University School of Medicine SPONSOR: Jeffrey Siracuse, MD

ANNOUNCES

Derek Afflu, MD University of Pittsburgh Medical Center MENTOR: Ryan McEnaney, MD

Frank Davis, MD University of Michigan Medical School MENTOR: Katherine Gallagher, MD

Katherine Hekman, MD, PhD Northwestern University, Feinberg School of Medicine MENTOR: Jason Wertheim, MD

Hallie Quiroz, MD University of Miami, Miller School of Medicine MENTOR: Omaida Velazquez, MD

Melissa Marie D'Andrea Loyola University Medical Center SPONSOR: Bernadette Aulivola, MD Natasha Ilyana Edman University of Washington SPONSOR: Matthew Penn Sweet, MD Charles Hamilton Robert Wood Johnson Medical School / Robert Wood Johnson University Hospital SPONSOR: William E. Beckerman, MD, RPVI

Louis Hinkle Houston Methodist Research Institute SPONSOR: Maham Rahimi, MD, PhD Yiyuan David Hu Harborview Medical Center SPONSOR: Benjamin Starnes, MD Katherine Jane Jensen University of Texas Health Science Center San Antonio Long School of Medicine SPONSOR: Paula K Shireman, MD Claire Motyl University of Rochester SPONSOR: Adam Doyle, MD Sascha Wodoslawsky Thomas Jefferson University Hospital SPONSOR: Babak Abai, MD

Stephen Hayes Eastern Virginia Medical School - Division of Vascular Surgery SPONSOR: Jean M. Panneton, MD

SVS Foundation Award Opportunities SVS FOUNDATION AWARD

WEBSITE

APPLICATION DEADLINE

Mentored Research Career Development Awards

VISIT: vsweb.org/MentoredResearch

NIH K Award Deadlines

Resident Research Award

VISIT:

vsweb.org/ResidentResearch

2021 VAM Abstract Deadline

VRIC Trainee Travel Award

VISIT:

vsweb.org/VRICScholarship

2021 VRIC Abstract Deadline

Student Research Fellowship

VISIT:

vsweb.org/StudentResearch

February 1, 2021

Clinical Research Seed Grant

VISIT:

vsweb.org/ClinicalResearchSeedGrant

March 1, 2021

E.J. Wylie Traveling Fellowship

VISIT:

vsweb.org/WylieTravel

March 1, 2021

Community Awareness and Prevention Project Grant

VISIT:

vsweb.org/CommunityGrants

March 1, 2021

Research Career Development Travel Award

VISIT:

vsweb.org/CareerTravel

To Be Announced

6

SVS F OU N DATI O N

| 2020 A N N UA L R E P O RT


LEGACY PROGR AM DONORS

The SVS Foundation's Legacy Program includes those who have contributed a total of $10,000 or more to the SVS Foundation during their lifetimes. They are honored in perpetuity for their commitment to the specialty.

The Legacy Program is grateful to every category of donor in this program:

Founder’s Circle

Director’s Circle

Benefactor’s Circle ($10,000 - $24,999)

American College of Surgeons

George Andros, MD

Anonymous Donor

Arthur I. Auer, MD

Joan L. and Julius H. Jacobson II

Richard P. Cambria, MD

Director’s Circle ($25,000-$49,999) President’s Circle ($50,000-$99,999) Chairman’s Circle ($100,000 - $499,999) Founder’s Circle ($500,000+) These contributors are leaders who best understand our specialty’s critical need for innovative researchers and the need to provide patient education for prevention of circulatory disease.

($500,000 – plus)

William J. von Liebig Foundation

Chairman’s Circle ($100,000 - $499,999)

Edwards Vascular Foundation James DeBord, MD

($25,000 - $49,999)

Alexander W. Clowes, MD†

Michael C. Dalsing, MD Susan Detweiler, MD

Division of Vascular and Endovascular Surgery, Massachusetts General Hospital Eastern Vascular Society Nicholas D. Garcia, MD

Peter and Karen Lawrence

Vivienne J. Halpern, MD

President’s Circle

New England Society for Vascular Surgery

($50,000 - $99,999)

C. Keith Ozaki, MD

Midwestern Vascular Surgical Society Society for Clinical Vascular Surgery Western Vascular Society

Southern Association for Vascular Surgery

William H. Pearce, MD

Daniel B. Walsh, MD and Teri Walsh, RN

Benefactor’s Circle (10,000 - $24,999) * If you note any omissions or corrections, please contact Allison Kohlbrenner at SVSFoundation@ vascularsociety.org or 312-334-2352. Early contributions to the Lifeline Foundation or the American Vascular Association® may not be reflected..

† Indicates deceased

John Abele Ali AbuRahma, MD K Ramesh Adiga, MD Samuel S. Ahn, MD Dennis F. Bandyk, MD Robert C. Batson, MD B. Timothy Baxter, MD John J. Bergen, MD† Victor M. Bernhard, MD Paul S. Brown Jr., MD Allan D. Callow, MD† Joseph E. Carney, MD G. Patrick Clagett, MD

Jon R. Cohen, MD E. Stanley Crawford, MD† Jack L. Cronenwett, MD Ronald L. Dalman, MD Herbert Dardik, MD† R. Clement Darling III, MD Mark G. Davies, MD, PhD David Deakins, MD Michael E. DeBakey, MD† Dominic A. DeLaurentis, MD† Ralph G. DePalma, MD James A. DeWeese, MD†

R. Howard Dobbs, MD Magruder C. Donaldson, MD William H. Edwards, MD Calvin B. Ernst, MD† Ronald M. Fairman, MD Rumi Faizer, MD William R. Flinn, MD Thomas L. Forbes, MD Julie Ann Freischlag, MD Bruce L. Gewertz, MD Gary Giangloa, MD Peter Gloviczki, MD 7


Benefactor’s Circle, continued

John F. Golan, MD Richard M. Green, MD Lazar J. Greenfield, MD Thomas J. Greenfield, MD Roger T. Gregory, MD John W. Hallett, Jr, MD Norman R. Hertzer, MD Robert W. Hobson II, MD† Glenn C. Hunter, MD Anthony M. Imparato, MD Bengt L. Ivarsson, MD George Johnson, Jr., MD† Robert L. Kistner, MD Larry W. Kraiss, MD Marvin E. Kuehner, MD Robert P. Leather, MD† Stephen E. Lee, MD Frank W. LoGerfo, MD Joseph G. Magnant, MD Michel S. Makaroun, MD William T. Maloney, MD John A. Mannick, MD Rebecca Maron, CAE Kenneth E. McIntyre, Jr., MD Joseph L. Mills, Sr., MD R. Scott Mitchell, MD Gregory L. Moneta, MD Wesley S. Moore, MD Robert W. Oblath, MD John L. Ochsner, MD† Kenneth, MD, and Joy Ouriel Malcolm Perry, MD† John J. Ricotta, MD Thomas S. Riles, MD Gary R. Seabrook, MD Pathanjali P.V. Sharma, MD Alexander D. Shepard, MD Gregorio A. Sicard, MD Robert B. Smith III, MD Ronald J. Stoney, MD David S. Sumner, MD† George T. Sugiyama, MD Vascular & Endovascular Surgery Society Frank J. Veith, MD Fred Weaver, MD Jock R. Wheeler, MD Anthony D. Whittemore, MD Samuel J. Williams, MD James S.T. Yao, MD, PhD Robert M. Zwolak, MD, PhD

8

SVS F OU N DATI O N

These organizations contributed to the

ORGANIZATION DONORS

SVS Foundation between April 1, 2019, and March 31, 2020.

SOCIETY CONTRIBUTORS

FOUNDATION CONTRIBUTORS

Society for Clinical Vascular Surgery

Edwards Vascular Foundation

Intersocietal Accreditation Commission American College of Surgeons

CORPORATE CONTRIBUTORS

SURGERY DEPARTMENT CONTRIBUTORS

Gore & Associates

University of Massachusetts Medical Center, Division of Vascular and Endovascular Surgery

Silk Road Medical Medtronic Jewish Federation of St. Louis The Benevity Community Impact Fund

The SVS Foundation thanks and appreciates INDIVIDUAL DONORS

all who contribute. These individuals and Donor Advised Funds made contributions to the SVS Foundation between April 1, 2019, and March 31, 2020.

GREATEST NEED (Annual Fund)

Oliver O. Aalami, MD Babak Abai, MD Mohammad Nabeel Abbasi, MD Thomas A. Abbruzzese, MD Ahmed M. Abou-Zamzam, Jr., MD Cherrie Abraham, MD Christopher J. Abularrage, MD Omran R. Abul-Khoudoud, MD, FACS Ali F. AbuRahma, MD John A. Adeniyi, MD, FACS Riad Adoumie, MD

| 2020 A N N UA L R E P O RT

Rana Afifi, MD Francesco A. Aiello, MD Georges E. Al-Khoury, MD Donald L. Akers, MD Hasan A. Aldailami, MD Babatunde H. Almaroof, MD, FACS Brett A. Almond, MD, PhD Daniel M. Alterman, MD, FACS, FSVS, RPVI Mohammed Al-Zoubaidi, MD, FACS, RPVI Kwame S. Amankwah, MD Anoushiravan Amini Hadjibashi, MD Iden Andacheh, MD Charles A. Andersen, MD

Leonard S. Anderson, MD George E. Anton, MD Edward J. Arous, MD Elias J. Arous, MD Shipra Arya, MD, SM, FACS Efthymios (Makis) Avgerinos, MD, FEBVS, DFSVS Charles Aycock William H. Baker, MD Nilesh N. Balar, MD, MBA, RVT Zachary K. Baldwin, MD Marcus Barber, MD Donald T. Baril, MD Neal R. Barshes, MD, MPH Bernard Timothy Baxter, MD Carlos Bechara, MD Adam W. Beck, MD


William H. Bell, III, MD Marshall E. Benjamin, MD Alan I. Benvenisty, MD Marcos Costa Berenguer, Jr., MD Eric Berens, MD Scott S Berman, MD, MHA James H. Black, MD John Blebea, MD, MBA Suellen Stevam Timotheo Bonadiman, MD Alexander Bonte, MD (MB, BCh, BAO) Stefano Bordoli, MD Jose Roberto M. Borromeo, MD April J. Boyd, MD, PhD, FRCSC Soma M. Brahmanandam, MD Peter B. Brant-Zawadzki, MD Lyle Breeding, MD Mark Joseph Brennan, DO, FACOS, RVT, RPhS, RPVI, RVS Luke Packard Brewster, MD, PhD Benjamin S. Brooke, MD, PhD Thomas E. Brothers, MD Paul Sherman Brown, Jr., MD Kevin J. Bruen, MD Shawna Mae Bucchere, PA-C Jason S. Burgess, MD James A. Burks, Jr., MD Patricia Burton, MS Ruth L. Bush, MD, JD, MPH Mark W. Byrge, DO John Stephen Byrne, MD Keith D. Calligaro, MD William Cuyler Calton Jr., MD Marcio Wilker Soares Campelo, MD, MSc., PhD Douglas Carlon, MD Gustavo A. Caserta, MD Marlin Wayne Causey, MD Sherry Cavanagh, MD, FACD, FSVS, RPVI Elliot L. Chaikof, MD Venita Chandra, MD Bill K. Chang, MD David Maurice Chatman, MD YiMing Avery Ching, MD Jae Sung Cho, MD Mary Chrisinger David P. Christenberry, MD Phillip J. Church, MD Rocco G. Ciocca, MD Paul Citrin, MD

Gregory Clabeaux, DO, FACOS, RPVI William Darrin Clouse, MD Abilio A. Coello, MD Salomon Cohen, MD, FACS Dawn M. Coleman, MD Paul S. Collins, MD James Mobley Combs, MD Peter Connolly, MD Michael J. Costanza, MD James E. Craven, MD Paul Crisostomo, MD, RPVI, FACS The Jack and Debra Cronenwett Charitable Fund Carlos P. Cruz, MD Robert F. Cuff, MD John A. Curci, MD Michael D. Dake, MD Carlo A. Dall'Olmo, MD Ronald L. Dalman, MD Michael C. Dalsing, MD Scott Michael Damrauer, MD R. Clement Darling, III, MD Mark G. Davies, MD, PhD Luis R. Davila-Santini, MD David L. Dawson, MD Gerard P. De Castro, MD, MPH Devendra B. Dekiwadia, MD Giacomo A. DeLaria, MD Randall Rich DeMartino, MD Richard J. DeMasi, MD Vincent Digiovanni, D.O. David Dockray, MD Carlos E. Donayre, MD Shernaz S. Dossabhoy, MD, MBA Adam J. Doyle, MD Anahita Dua, MD Luc Dubois, MD Audra A. Duncan, MD Son T. Duong, MD Joseph R. Durham, MD Yazan Duwayri, MD Matthew J. Eagleton, MD Eugene Eddlemon, MD Mark T. Eginton, MD Sharif Ellozy, MD James R. Elmore, MD Sean J. English, MD Young Erben, MD Luke Stephan Erdoes, MD Mark K. Eskandari, MD Jaime Gerardo Estrada, MD Yana Etkin, MD Ronald M. Fairman, MD

Andres Fajardo, MD Tony D. Fang Alik Farber, MD Delton L. Farquharson, MBBS, FRCSC, FACS Ziad Fayad, MD Robert J. Feezor, MD Giovanni A. Ferrante, MD John J. Flanagan, MD Arthur Flatau, III, MD, FACS Thomas L. Forbes, MD Richard J. Fowl, MD Michael B. Freeman, MD Patricia C. Furey, MD Dennis R. Gable, MD Yves A. Gabriel, MD John F. Gallagher, MD Katherine A. Gallagher, MD Manuel Garcia-Toca, MD Robert M. Gasior, MD Michael Ellis Gaunt, MD, FRCS XiaoHu Ge Randolph L. Geary, MD Stephen M. Gemmett, MD Elizabeth Anne Genovese, MD, MS Shaun M. Gifford, MD Julia Glaser, MD Natalia Glebova, MD, PhD, FACS, FSVS Peter Gloviczki, MD James M. Goff, Jr., MD Marat Goldenberg, MD Irene Goldstein, MD Christopher Goltz, MD Andrew Alexander Gonzalez, MD, JD, MPH Vitor Cervantes Gornati, MD, PhD Rachel Allison Grinnan, DO Prem C. Gupta, MD Raul J. Guzman, MD Vincent J. Guzzetta, MD Eric S. Hager, MD Kevin D. Halow, MD David C. Han, MD Daniel K. Han, MD, FACS, RPVI Dinah Hanna, MD, FACS Sachinder S. Hans, MD Shahid N. Haque, MD, FACS Russell N. Harada, MD Catalin Harbuzariu, MD, FACS Linda M. Harris, MD Ravishankar Hasanadka, MD Takuya Hashimoto, MD, PhD

Peter K. Henke, MD Diego A. Hernandez, MD Richard Hershberger, MD Caitlin Whitney Hicks, MD, MS Anil P. Hingorani, MD Jamal J. Hoballah, MD Kim J. Hodgson, MD, DFSVS Jessica Louise Hogan, MD Kakra Hughes, MD Jason Richard Hurd, MD Justin B. Hurie, MD James Iannuzzi, MD, MPH Ralph P. Ierardi, MD Daniel M. Ihnat, MD Karl A. Illig, MD Giulio Illuminati, MD Benjamin M. Jackson, MD Fernando L. Joglar, MD Kaj H. Johansen, MD, PhD, FACS Brad L. Johnson, MD K. Wayne Johnston, MD William D. Jordan, Jr. MD Dejah R. Judelson, MD Loay S. Kabbani, MD, MHAS Ajith K. Kadakol, MD Peter E. Kagan, MD Steven S. Kang, MD Nikhil Kansal, MD Vikram S. Kashyap, MD Gregory C. Kasper, MD Michael P. Keller, MD Brian Kelly, MD Nicole A. Kennedy, MD Muhammad Asad Khan, MD Melina R. Kibbe, MD Michael J. Kikta, MD Terry A. King, MD Alison Kinning, MD Dr. Robert L. and Adelaide Kistner Gift Fund Sarah Elizabeth Koch, MD Issam Koleilat, MD George J. Koullias, MD Larry W. Kraiss, MD Timothy F. Kresowik, MD Shameem S. Kunhammed, MD Kara H.V. Kvilekval, MD Christopher J. Kwolek, MD Chris LaGraize, MD Russell C. Lam, MD Michael E. Landis, MD Robert A. Larson, MD Peter F. Lawrence, MD Jason T. Lee, MD Cheong J. Lee, MD

9


Direct Dollars to Favorite Fund The SVS Foundation provides donors the opportunity to direct their dollars to specific areas of interest. A contributor could have the zeal to fund the SVS Foundation’s core mission of research, or the new community initiatives, or simply the area of greatest need. The SVS Foundation funds include: GREATEST NEED (Annual Fund)

DISASTER RELIEF FUND

Gifts to this unrestricted fund will ensure that there will always be a resource to address projects that need funding.

This fund provides short-term emergency assistance and longer-term aid for vascular surgery practices and vascular patients in disaster-devastated communities.

AWARENESS AND PREVENTION (Community Health Initiatives)

ALEXANDER W. CLOWES DISTINGUISHED LECTURE FUND

Donations support our expanded mission in disease prevention, patient education and public awareness.

Honor the memory of our colleague and internationally recognized vascular surgeon-scientist, Dr. Alexander W. Clowes, by supporting the annual lecture at the Vascular Research Initiatives Conference.

RESEARCH GRANTS

Contributions support the SVS Foundation’s core mission— to crucial vascular research that improves patient health. Awards support researchers at all levels of their careers.

Michael A. Leke, MD Gary W. Lemmon, MD Charles J. Lewinstein, MD Nathan Liang, MD Thomas F. Lindsay, MDCM, MSc Maria E. Litzendorf, MD Meryl Simon Logan, MD Paul Robert Long, MD Rene Mario Loyola, MD Layla Corral Lucas, MD Ying Wei Lum, MD, MPH Fedor Lurie, MD, PhD, RPVI, RVT Richard A. Lynn, MD, FACS, RPVI Kent MacKenzie, MD Robyn A. Macsata, MD Kenneth R. Madsen, MD Gregory A. Magee, MD, MSc Patrick A. Mahon, MD, FACS Jacqueline Majors, MD Michel S. Makaroun, MD Lawrence I. Mallon, MD Kristyn A. Mannoia, MD M. Ashraf Mansour, MD, FACS Megan Irene March, MD

10

SVS F OU N DATI O N

Silviu C. Marica, MD Luke K. Marone, MD Brent D. Marsden, MD William A. Marston, MD John H. Matsuura, MD Mark A. Mattos, MD, DFSVS, FACS Stacey Mazzacco, MD Robert A. McCready, MD Daniel T. McDevitt, MD Ryan M. McEnaney, MD Daniel J. McLaughlin, MD James W. McNeil, MD George H. Meier, MD Donna M. Mendes, MD Nelson S. Menezes, MD Louis M. Messina, MD Roy Miler, MD Joseph L. Mills, MD Samantha D. Minc, MD Erica Leith Mitchell, MD, MEd SE, FACS, DFSVS Mark J. Mittenthal, MD Nicola Molinaro Robert G. Molnar, MD Gregory L. Moneta, MD Samuel R. Money, MD

| 2020 A N N UA L R E P O RT

Ricardo E. Morales, PA-C Leonardo Martins Mota De Morais, MD Nicolas J. Mouawad, MD, MPH, MBA, RPVI Dipankar Mukherjee, MD John R. Mullins, MD Stephen P. Murray, MD Scott E. Musicant, MD Firas F. Mussa, MD, MS, FACS Ryan D. Nachreiner, MD Deepak G. Nair, MD, MS, RVT Massimo Mark Napolitano, MD Ramesh C. Narayanagowda, MD Todd J. Neuberger, MD Carlos Neves, MD Richard F. Neville, MD Gary Nishanian, MD Ryan Nicholas Nolte, MD Marc A. Norris, MD Andrea Obi, MD Christian J. Ochoa, MD Lyssa N. Ochoa, MD Thomas F. O'Donnell, MD

Paul Lawrence O'Donnell, DO Ricardo de Avila Oliveira, MD, PhD William Frank Oppat, MS, MD Lawrence Oresanya, MD Zachary Osborne, MD Nicholas H. Osborne, MD Christine Ou, DO David J. Paolini, MD Heather P. Park, MD Garri Pasklinsky, MD Marc A. Passman, MD Jacek Paszkowiak, MD Amit V. Patel, MD Megan Patterson Robert B. Patterson, MD R. Michael Patton, MD Benjamin J. Pearce, MD, FACS Richard C. Pennell, MD Bruce Alan Perler, MD, MBA Giancarlo Piano, MD Gilles C.J. Pinault, MD Edward J. Plecha, MD Chris W. Pollock, MD Frank B. Pomposelli, MD


Lori C. Pounds, MD Richard J. Powell, MD Elina Quiroga, MD Joseph D. Raffetto, MD Kevin B. Raftery, MD Ravi Rajani, MD Seshadri Raju, MD Denis P. Raleigh, MD Subhash C. Ramnauth, MD Joseph H. Rapp, MD Pritham Reddy, MD Rebecca Anne Reynolds, AGACNP-BC Michael A. Ricci, MD Hugh F. Richardson, Jr. Aksim Rivera, MD Andrew B. Roberts, MD James Roberts, MD, RVT, FACS Caron B. Rockman, MD Sean P. Roddy, MD Michael J. Rohrer, MD Carlos A. Rosales Robin Rose, PA-C Charles B. Ross, MD Peter J. Rossi, MD Todd E. Russell, MD Patrick C. Ryan, MD Ulka Sachdev, MD Jacob Evan Sadeck, PA-C David M. Sailors, MD Clifford M. Sales, MD Lawrence N. Sampson, MD Luis A. Sanchez, MD Timur P. Sarac, MD Andres Schanzer, MD Marc L. Schermerhorn, MD Peter A. Schneider, MD Gary R. Seabrook, MD Marcus Semel, MD Jon Senkowsky, MD Piergiorgio G. Settembrini, MD, FEBVS Parth S. Shah, MD, MPH, FACS Raymond M. Shaheen, MD Sherene Shalhub, MD, MPH Anton Sharapov, MD Saadat Shariff, MD Pathanjali P.V. Sharma, MD Palma M. Shaw, MD Kevin Sheridan, MD Lynn H. Shin, MD Paula Shireman, MD Christine Shokrzadeh, MD

Peyser-Shortell Gifting Bing Shue, MD Mrinal Shukla, MD Frederick W. Shuler, MD, FACS Shutze Giving Fund William P. Shutze, MD Gregorio A. Sicard, MD Anton N. Sidawy, MD, MPH Matthew J. Sideman, MD Ravindar S. Sidhu, MD Jessica P. Simons, MD, MPH Tej M. Singh, MD Niten Singh, MD Mark Alan Sinning Mahalingham Sivakumar, MD Christopher L. Skelly, MD Kenneth M. Slaw, PhD Alessandro G. Smeraldi, MD, RVT Christopher J. Smolock, MD Maurice M. Solis, MD Michael Clarkston Soult, MD Andreas M. Spirig, MD Sunita D. Srivastava, MD Benjamin W. Starnes, MD Robert C. Steppacher, MD W. Charles Sternbergh, MD Gordon K. Stokes, MD Ronald J. Stoney, MD Christopher L. Stout, MD Rishi Subbarayan, MD Theodore R. Sullivan, MD Scott M. Surowiec, MD Matthew P. Sweet, MD Pinkus Szuchmacher, MD Tiziano Tallarita, MD Anjan Talukdar, MD Gale L. Tang, MD Gary Tannenbaum, MD Stephens D. Taylor, MD, MBA Marcelo Passos Teivelis, MD, PhD Victoria J. Teodorescu, MD Theodore H. Teruya, MD Desarom Teso, MD Charles Thompson, MD Robert K. Thompson III, MD Bryan W. Tillman, MD Fabio Andre Tornquist Sr., MD Margaret C. Tracci, MD JD Hoang S. Tran, MD, RVT, RPVI Jose Trani Jr., MD

Alexander S. Tretinyak, MD Ramesh K. Tripathi, MD, FRCS, FRACS Shirling Tsai, MD Arthelma Chenee Tyson, MD Edith Tzeng, MD Areck Ucuzian, MD, PhD Naoki Unno, MD Gilbert R. Upchurch Jr., MD Patrick S. Vaccaro, MD Julio C. Vasquez, MD Mario Vasquez Hernandez, MD Paul A. Vieta Jr., MD Gilford S. Vincent, MD Uthan Vivek, MD Arno B. Von Ristow, MD Ivica V. Vucemilo, MD, FRCS(C) Jim and Sally Wagner Charitable Gift Fund Thomas W. Wakefield, MD Justin R. Wallace, MD James Walwark Grace J. Wang, MD Fred A. Weaver, MD Thomas H. Webb III, MD Victor J. Weiss, MS, MD, RVT Franklin W. West, RN Benjamin Westbrook, MD Scott G. Westfall, MD Grayson H. Wheatley III, MD Paul W. White, MD John V. White, MD Rodney A. White, MD William F. Whitehead, MD Douglas B. Wilhite, MD, FACS Richard J. Wilkerson, MD Clay Wiske, MD Edward Y. Woo, MD Karen Woo, MD Xenophon Xenophontos, MD Dai Yamanouchi, MD, PhD Theodore H. Yuo, MD, MSc Mohamed A. Zayed, MD, PhD Jack Zeltzer, MD Wei Zhou, MD Kenneth Richard Ziegler, MD Jill Zink, MD Robert M. Zwolak, MD, PhD

CLOWES DISTINGUISHED LECTURE FUND

Luke Packard Brewster, MD, PhD DISASTER RELIEF FUND

Raghu L. Motaganahalli, MD RESEARCH FUND

Beth Bales Jayer Chung, MD Paul B. Haser, MD, FACS, FRCSC Karen J. Ho, MD Jason N. MacTaggart, MD Peter R. Nelson, MD, MS

11


DONORS HAVE A MULTITUDE OF WAYS TO MAKE CONTRIBUTIONS TO THE SVS FOUNDATION.

Our supporters enable the SVS Foundation to fulfill its mission to support not only the next generation of surgeon-scientists but also education, patient awareness and disease prevention.

How toGive TO TH E

• Cash, Check, Credit Card • While paying your SVS Dues • Stocks • Donor Advised Funds • IRA Rollover (tax advantages for those 70.5 years of age and older) • Wills/Revocable Trusts • Life Insurance • Charitable Gift Annuities In addition, the SVS Foundation deeply values partnership with industry on education, research and patient awareness efforts

Please help us help our vascular families—our patients, our researchers and everyone in between. Donate now at vsweb.org/GIVE.

©2020 Society for Vascular Surgery Foundation 9400 W. Higgins Road, Suite 315 Rosemont, IL 60018-4975 Phone: 312-334-2300 / 800-258-7188

Profile for Society for Vascular Surgery

SVS Foundation 2020 Annual Report  

SVS Foundation 2020 Annual Report  

Recommendations could not be loaded

Recommendations could not be loaded

Recommendations could not be loaded

Recommendations could not be loaded